- $9.62bn
- $10.04bn
- $2.71bn
Insulet rises after Q1 results beat
US STOCKS-Wall Street rises as focus shifts to US-China trade talks
Insulet rises after Q1 results
U.S. RESEARCH ROUNDUP-Hubspot, Insulet, Sharkninja
Insulet Corp reports results for the quarter ended March 31 - Earnings Summary
Insulet beats quarterly profit estimates on insulin pump demand
Morning Bid Americas: UK eyes 'major trade deal'
Insulet rises after co names new CEO, signals improved rev outlook
Brief: Insulet Appoints Ashley McEvoy President And CEO
U.S. STOCKS ON THE MOVE-Oil firms, State Street, Dexcom
U.S. STOCKS ON THE MOVE-Lockheed Martin, KeyCorp, Global Payments
U.S. STOCKS ON THE MOVE-Eli Lilly, Plug Power, Snap-On
U.S. STOCKS ON THE MOVE-UnitedHealth Group, Marex Group, Snap-On
Diabetes device makers fall after data on Lilly's weight loss pill
US medical device makers decline after reciprocal tariffs on China, Mexico
Brief: Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system
Brief: Insulet announces pricing of senior notes due 2033
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot